IRCT20180514039657N1 IRCT 2018-06-22 Ahvaz University of Medical Sciences effects of taurine in traumatic brain injury Effects of Taurine Powder Supplementation on Inflammatory Markers and Clinical Outcomes in Traumatic Brain Injury Patients Admitted to the Intensive Care Unit 2018-06-10 anticipated 44 Complete https://irct.ir/trial/31173 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Assignment of patients to each groups is done by random block method using block of size 6.In order to ensure that the selection bias does not occur, the allocation method is used to allocate a unique code to each patient, Blinding description: the type of blinding in our study is double-blind. Taurine powder is dissolved by an individual except the researcher in the gavage solution and is coded as A and B, so that the investigator will not be informed of the patient's receipt or not of Taurine. Patients are randomly allocated to each group A and B. 2-3 traumatic brain injury. Intervention 1: Intervention group: standard entrameal of karen pharma with taurine powder with a dose 30 mg/kg in two divided doses per day for 14 days. Intervention 2: Control group: standard entrameal of karen pharma for 14 days. Yes - There is a plan to make this available What will be shared: If the decision is to publicate the data, after the unidentified individuals all data will be publicated. When: The access period will be 6 months after the publication of the results. To whom: Researchers working in academic and industrial institutions can apply to get data. Conditions: To cite. Referring to reference or researcher's permission Where to obtain: Mahsa Vahdat. Faculty of Paramedicine, jundishapur University of Medical Sciences, golestan Blvd, Ahvaz. vahdat.m@ajums.ac.ir How to obtain: Access to articles related to this research Send email to the responsible author Comments: